The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccines For Children Market Research Report 2025
Synopsis
Childhood vaccination against diseases such as measles, meningitis and pneumonia, helps protect the developing immune systems of infants and prevents 2-3 million childhood deaths every year
The global Vaccines For Children market was valued at US$ 11810 million in 2023 and is anticipated to reach US$ 17290 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccines For Children, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines For Children.
Report Scope
The Vaccines For Children market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines For Children market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines For Children manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Johnson & Johnson
Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccines For Children manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccines For Children in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Childhood vaccination against diseases such as measles, meningitis and pneumonia, helps protect the developing immune systems of infants and prevents 2-3 million childhood deaths every year
The global Vaccines For Children market was valued at US$ 11810 million in 2023 and is anticipated to reach US$ 17290 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccines For Children, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines For Children.
Report Scope
The Vaccines For Children market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines For Children market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines For Children manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Johnson & Johnson
Segment by Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccines For Children manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccines For Children in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vaccines For Children Market Overview
1.1 Product Overview and Scope of Vaccines For Children
1.2 Vaccines For Children Segment by Type
1.2.1 Global Vaccines For Children Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines For Children Segment by Application
1.3.1 Global Vaccines For Children Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Vaccines For Children Market Size Estimates and Forecasts
1.4.1 Global Vaccines For Children Revenue 2019-2030
1.4.2 Global Vaccines For Children Sales 2019-2030
1.4.3 Global Vaccines For Children Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaccines For Children Market Competition by Manufacturers
2.1 Global Vaccines For Children Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaccines For Children Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaccines For Children Average Price by Manufacturers (2019-2024)
2.4 Global Vaccines For Children Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccines For Children, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccines For Children, Product Type & Application
2.7 Vaccines For Children Market Competitive Situation and Trends
2.7.1 Vaccines For Children Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccines For Children Players Market Share by Revenue
2.7.3 Global Vaccines For Children Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccines For Children Retrospective Market Scenario by Region
3.1 Global Vaccines For Children Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaccines For Children Global Vaccines For Children Sales by Region: 2019-2030
3.2.1 Global Vaccines For Children Sales by Region: 2019-2024
3.2.2 Global Vaccines For Children Sales by Region: 2025-2030
3.3 Global Vaccines For Children Global Vaccines For Children Revenue by Region: 2019-2030
3.3.1 Global Vaccines For Children Revenue by Region: 2019-2024
3.3.2 Global Vaccines For Children Revenue by Region: 2025-2030
3.4 North America Vaccines For Children Market Facts & Figures by Country
3.4.1 North America Vaccines For Children Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaccines For Children Sales by Country (2019-2030)
3.4.3 North America Vaccines For Children Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccines For Children Market Facts & Figures by Country
3.5.1 Europe Vaccines For Children Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaccines For Children Sales by Country (2019-2030)
3.5.3 Europe Vaccines For Children Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines For Children Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccines For Children Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaccines For Children Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaccines For Children Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccines For Children Market Facts & Figures by Country
3.7.1 Latin America Vaccines For Children Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaccines For Children Sales by Country (2019-2030)
3.7.3 Latin America Vaccines For Children Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccines For Children Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines For Children Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaccines For Children Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaccines For Children Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vaccines For Children Sales by Type (2019-2030)
4.1.1 Global Vaccines For Children Sales by Type (2019-2024)
4.1.2 Global Vaccines For Children Sales by Type (2025-2030)
4.1.3 Global Vaccines For Children Sales Market Share by Type (2019-2030)
4.2 Global Vaccines For Children Revenue by Type (2019-2030)
4.2.1 Global Vaccines For Children Revenue by Type (2019-2024)
4.2.2 Global Vaccines For Children Revenue by Type (2025-2030)
4.2.3 Global Vaccines For Children Revenue Market Share by Type (2019-2030)
4.3 Global Vaccines For Children Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaccines For Children Sales by Application (2019-2030)
5.1.1 Global Vaccines For Children Sales by Application (2019-2024)
5.1.2 Global Vaccines For Children Sales by Application (2025-2030)
5.1.3 Global Vaccines For Children Sales Market Share by Application (2019-2030)
5.2 Global Vaccines For Children Revenue by Application (2019-2030)
5.2.1 Global Vaccines For Children Revenue by Application (2019-2024)
5.2.2 Global Vaccines For Children Revenue by Application (2025-2030)
5.2.3 Global Vaccines For Children Revenue Market Share by Application (2019-2030)
5.3 Global Vaccines For Children Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Vaccines For Children Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Vaccines For Children Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Vaccines For Children Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Vaccines For Children Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Jintan
6.5.1 Jintan Corporation Information
6.5.2 Jintan Description and Business Overview
6.5.3 Jintan Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jintan Vaccines For Children Product Portfolio
6.5.5 Jintan Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CSL Vaccines For Children Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 MedImmune LLC
6.6.1 MedImmune LLC Corporation Information
6.6.2 MedImmune LLC Description and Business Overview
6.6.3 MedImmune LLC Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MedImmune LLC Vaccines For Children Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Corporation Information
6.8.2 J&J(Crucell) Description and Business Overview
6.8.3 J&J(Crucell) Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.8.4 J&J(Crucell) Vaccines For Children Product Portfolio
6.8.5 J&J(Crucell) Recent Developments/Updates
6.9 China National Biotec
6.9.1 China National Biotec Corporation Information
6.9.2 China National Biotec Description and Business Overview
6.9.3 China National Biotec Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China National Biotec Vaccines For Children Product Portfolio
6.9.5 China National Biotec Recent Developments/Updates
6.10 Tiantan
6.10.1 Tiantan Corporation Information
6.10.2 Tiantan Description and Business Overview
6.10.3 Tiantan Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tiantan Vaccines For Children Product Portfolio
6.10.5 Tiantan Recent Developments/Updates
6.11 Hualan
6.11.1 Hualan Corporation Information
6.11.2 Hualan Vaccines For Children Description and Business Overview
6.11.3 Hualan Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Vaccines For Children Product Portfolio
6.11.5 Hualan Recent Developments/Updates
6.12 Kangtai
6.12.1 Kangtai Corporation Information
6.12.2 Kangtai Vaccines For Children Description and Business Overview
6.12.3 Kangtai Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kangtai Vaccines For Children Product Portfolio
6.12.5 Kangtai Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Corporation Information
6.13.2 Hissen Vaccines For Children Description and Business Overview
6.13.3 Hissen Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hissen Vaccines For Children Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Corporation Information
6.14.2 Johnson & Johnson Vaccines For Children Description and Business Overview
6.14.3 Johnson & Johnson Vaccines For Children Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Johnson & Johnson Vaccines For Children Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines For Children Industry Chain Analysis
7.2 Vaccines For Children Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines For Children Production Mode & Process
7.4 Vaccines For Children Sales and Marketing
7.4.1 Vaccines For Children Sales Channels
7.4.2 Vaccines For Children Distributors
7.5 Vaccines For Children Customers
8 Vaccines For Children Market Dynamics
8.1 Vaccines For Children Industry Trends
8.2 Vaccines For Children Market Drivers
8.3 Vaccines For Children Market Challenges
8.4 Vaccines For Children Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
